| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Osteoarthritis, Knee | 3 | 2018 | 158 | 1.76 | Why? |
| Fatty Liver, Alcoholic | 2 | 2018 | 13 | 1.46 | Why? |
| Bone Density | 3 | 2019 | 335 | 1.28 | Why? |
| Geriatric Assessment | 8 | 2021 | 1372 | 1.19 | Why? |
| Frail Elderly | 7 | 2019 | 1427 | 1.16 | Why? |
| Sarcopenia | 3 | 2021 | 422 | 1.08 | Why? |
| Depressive Disorder | 3 | 2019 | 1236 | 0.98 | Why? |
| Diet, Vegetarian | 2 | 2019 | 31 | 0.97 | Why? |
| Diet | 4 | 2018 | 2052 | 0.93 | Why? |
| Non-alcoholic Fatty Liver Disease | 3 | 2018 | 907 | 0.81 | Why? |
| Caloric Restriction | 2 | 2019 | 56 | 0.80 | Why? |
| Magnesium | 2 | 2021 | 290 | 0.75 | Why? |
| Nutritional Physiological Phenomena | 1 | 2019 | 100 | 0.71 | Why? |
| Antidepressive Agents | 3 | 2018 | 509 | 0.71 | Why? |
| Dance Therapy | 1 | 2017 | 13 | 0.70 | Why? |
| Bone Regeneration | 1 | 2017 | 35 | 0.68 | Why? |
| Solanum tuberosum | 1 | 2017 | 27 | 0.67 | Why? |
| Financing, Personal | 1 | 2018 | 113 | 0.66 | Why? |
| Coffee | 1 | 2018 | 79 | 0.66 | Why? |
| Gene-Environment Interaction | 1 | 2017 | 127 | 0.64 | Why? |
| Diet, Mediterranean | 2 | 2018 | 351 | 0.64 | Why? |
| Cooking | 1 | 2017 | 144 | 0.64 | Why? |
| After-Hours Care | 1 | 2017 | 82 | 0.63 | Why? |
| Osteoarthritis | 1 | 2019 | 205 | 0.63 | Why? |
| Enteral Nutrition | 1 | 2019 | 320 | 0.63 | Why? |
| Menopause | 1 | 2018 | 136 | 0.62 | Why? |
| Neuropsychological Tests | 2 | 2017 | 954 | 0.57 | Why? |
| Hospital Costs | 1 | 2018 | 274 | 0.57 | Why? |
| Cell Differentiation | 2 | 2018 | 1338 | 0.54 | Why? |
| Dementia | 4 | 2021 | 1861 | 0.53 | Why? |
| Fatty Liver | 1 | 2018 | 299 | 0.52 | Why? |
| Physical Fitness | 1 | 2017 | 334 | 0.52 | Why? |
| Fasting | 1 | 2019 | 555 | 0.52 | Why? |
| Antitubercular Agents | 2 | 2018 | 775 | 0.52 | Why? |
| Nursing Homes | 5 | 2021 | 4155 | 0.51 | Why? |
| Accidental Falls | 1 | 2017 | 448 | 0.48 | Why? |
| Bipolar Disorder | 5 | 2018 | 744 | 0.48 | Why? |
| Neoplasm Staging | 4 | 2018 | 1999 | 0.47 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2017 | 584 | 0.46 | Why? |
| Stem Cell Transplantation | 1 | 2017 | 531 | 0.45 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.45 | Why? |
| Fractures, Bone | 1 | 2017 | 487 | 0.43 | Why? |
| Exercise Test | 1 | 2017 | 911 | 0.42 | Why? |
| Hip Fractures | 1 | 2018 | 667 | 0.41 | Why? |
| Aging | 4 | 2021 | 3581 | 0.39 | Why? |
| Biomarkers, Tumor | 4 | 2019 | 1314 | 0.38 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.37 | Why? |
| Frailty | 2 | 2019 | 1432 | 0.37 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 1115 | 0.36 | Why? |
| Aged | 46 | 2021 | 215776 | 0.36 | Why? |
| Vitamin D | 3 | 2018 | 2904 | 0.36 | Why? |
| Health Status | 2 | 2019 | 3259 | 0.35 | Why? |
| Diet, Protein-Restricted | 2 | 2018 | 80 | 0.35 | Why? |
| Suicide | 1 | 2021 | 1500 | 0.35 | Why? |
| Cognition | 1 | 2017 | 1394 | 0.34 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.34 | Why? |
| Diet Surveys | 2 | 2018 | 152 | 0.34 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.34 | Why? |
| Lymph Nodes | 4 | 2018 | 1060 | 0.34 | Why? |
| Alzheimer Disease | 1 | 2017 | 1020 | 0.33 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 1454 | 0.33 | Why? |
| Carcinoma, Pancreatic Ductal | 2 | 2018 | 112 | 0.33 | Why? |
| Lumbar Vertebrae | 2 | 2018 | 196 | 0.32 | Why? |
| Inpatients | 2 | 2021 | 5161 | 0.32 | Why? |
| Postmenopause | 2 | 2019 | 160 | 0.32 | Why? |
| Nutritional Status | 1 | 2017 | 1403 | 0.32 | Why? |
| Odds Ratio | 8 | 2019 | 5861 | 0.32 | Why? |
| Longitudinal Studies | 7 | 2019 | 9893 | 0.32 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2016 | 2483 | 0.31 | Why? |
| Disabled Persons | 1 | 2017 | 1152 | 0.31 | Why? |
| Mortality | 2 | 2021 | 7132 | 0.30 | Why? |
| Depression | 7 | 2020 | 14116 | 0.29 | Why? |
| Humans | 94 | 2021 | 930598 | 0.29 | Why? |
| Female | 52 | 2021 | 380317 | 0.29 | Why? |
| Social Determinants of Health | 1 | 2017 | 1757 | 0.28 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.28 | Why? |
| Nutrition Assessment | 2 | 2019 | 527 | 0.27 | Why? |
| Head and Neck Neoplasms | 1 | 2017 | 1568 | 0.27 | Why? |
| Liver | 2 | 2018 | 4007 | 0.27 | Why? |
| Male | 49 | 2021 | 367725 | 0.25 | Why? |
| Cause of Death | 1 | 2017 | 4823 | 0.25 | Why? |
| Prognosis | 17 | 2021 | 32490 | 0.25 | Why? |
| Aged, 80 and over | 23 | 2021 | 88759 | 0.25 | Why? |
| Magnetic Resonance Imaging | 6 | 2018 | 6551 | 0.25 | Why? |
| Fatty Acids, Omega-6 | 2 | 2019 | 43 | 0.24 | Why? |
| Genetic Predisposition to Disease | 1 | 2017 | 4027 | 0.24 | Why? |
| Nervous System Diseases | 1 | 2021 | 4092 | 0.24 | Why? |
| Quality of Life | 4 | 2020 | 9820 | 0.23 | Why? |
| Coronary Artery Disease | 1 | 2017 | 2570 | 0.23 | Why? |
| Adenocarcinoma | 3 | 2017 | 651 | 0.23 | Why? |
| Patient Safety | 1 | 2017 | 4885 | 0.23 | Why? |
| Osteoclasts | 2 | 2018 | 67 | 0.22 | Why? |
| Independent Living | 2 | 2018 | 842 | 0.22 | Why? |
| Transcription Factors | 2 | 2017 | 784 | 0.22 | Why? |
| Eicosapentaenoic Acid | 2 | 2019 | 106 | 0.22 | Why? |
| Appendicitis | 2 | 2021 | 946 | 0.22 | Why? |
| Length of Stay | 2 | 2021 | 11042 | 0.22 | Why? |
| Geriatricians | 1 | 2021 | 71 | 0.22 | Why? |
| Magnesium Deficiency | 1 | 2021 | 28 | 0.21 | Why? |
| Schistosomiasis | 1 | 2021 | 59 | 0.21 | Why? |
| Proportional Hazards Models | 6 | 2019 | 6543 | 0.21 | Why? |
| Epidemics | 1 | 2021 | 6407 | 0.21 | Why? |
| Pancreatic Neoplasms | 2 | 2018 | 609 | 0.21 | Why? |
| Inflammation | 3 | 2019 | 13255 | 0.21 | Why? |
| Malnutrition | 3 | 2019 | 932 | 0.21 | Why? |
| Neoplasm Recurrence, Local | 2 | 2018 | 1063 | 0.20 | Why? |
| Italy | 10 | 2021 | 38444 | 0.20 | Why? |
| Antipsychotic Agents | 3 | 2018 | 887 | 0.20 | Why? |
| Spinal Fractures | 2 | 2018 | 124 | 0.20 | Why? |
| C-Reactive Protein | 1 | 2016 | 7972 | 0.20 | Why? |
| Middle Aged | 33 | 2021 | 270681 | 0.20 | Why? |
| Colorectal Neoplasms | 3 | 2019 | 1884 | 0.20 | Why? |
| Osteoporotic Fractures | 2 | 2019 | 175 | 0.20 | Why? |
| Lipoproteins, VLDL | 1 | 2018 | 8 | 0.20 | Why? |
| Vasomotor System | 1 | 2019 | 13 | 0.20 | Why? |
| Vegetarians | 1 | 2019 | 17 | 0.19 | Why? |
| Hot Flashes | 1 | 2019 | 20 | 0.19 | Why? |
| Back Muscles | 1 | 2018 | 11 | 0.19 | Why? |
| Sweating | 1 | 2019 | 52 | 0.19 | Why? |
| Arachidonic Acid | 1 | 2019 | 90 | 0.19 | Why? |
| Telomere Homeostasis | 1 | 2019 | 52 | 0.19 | Why? |
| Primary Health Care | 1 | 2017 | 4839 | 0.18 | Why? |
| Elder Nutritional Physiological Phenomena | 1 | 2018 | 8 | 0.18 | Why? |
| Osteocalcin | 1 | 2018 | 31 | 0.18 | Why? |
| Exercise | 5 | 2021 | 6771 | 0.18 | Why? |
| Self Administration | 1 | 2018 | 125 | 0.18 | Why? |
| Risk | 4 | 2019 | 5288 | 0.18 | Why? |
| Randomized Controlled Trials as Topic | 8 | 2018 | 10649 | 0.18 | Why? |
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2018 | 78 | 0.18 | Why? |
| Interleukin-6 | 1 | 2016 | 7522 | 0.18 | Why? |
| Catechol O-Methyltransferase | 1 | 2017 | 25 | 0.18 | Why? |
| Body Mass Index | 4 | 2019 | 4306 | 0.18 | Why? |
| Neoplasms, Adipose Tissue | 1 | 2017 | 1 | 0.18 | Why? |
| Cartilage, Articular | 1 | 2018 | 50 | 0.18 | Why? |
| Recommended Dietary Allowances | 1 | 2017 | 43 | 0.18 | Why? |
| Paliperidone Palmitate | 1 | 2017 | 24 | 0.18 | Why? |
| Cross-Sectional Studies | 16 | 2021 | 53120 | 0.18 | Why? |
| Plant Tubers | 1 | 2017 | 11 | 0.18 | Why? |
| Lithium | 1 | 2018 | 56 | 0.18 | Why? |
| Neurobiology | 1 | 2017 | 12 | 0.18 | Why? |
| Premenopause | 1 | 2018 | 63 | 0.18 | Why? |
| Psychopharmacology | 1 | 2017 | 18 | 0.18 | Why? |
| Incidence | 7 | 2020 | 25622 | 0.18 | Why? |
| Chemoradiotherapy, Adjuvant | 1 | 2017 | 69 | 0.17 | Why? |
| Patient Compliance | 2 | 2018 | 1468 | 0.17 | Why? |
| Respiratory Distress Syndrome, Newborn | 1 | 2018 | 124 | 0.17 | Why? |
| Muscle Weakness | 2 | 2018 | 406 | 0.17 | Why? |
| Income | 5 | 2017 | 1564 | 0.17 | Why? |
| Risk Factors | 13 | 2018 | 71621 | 0.17 | Why? |
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 198 | 0.17 | Why? |
| Telomere | 1 | 2019 | 146 | 0.17 | Why? |
| Exercise Therapy | 2 | 2017 | 976 | 0.17 | Why? |
| Waist Circumference | 1 | 2018 | 199 | 0.17 | Why? |
| Mediterranean Region | 1 | 2018 | 276 | 0.16 | Why? |
| Hand Strength | 1 | 2018 | 202 | 0.16 | Why? |
| Pulmonary Surfactants | 1 | 2018 | 128 | 0.16 | Why? |
| Educational Status | 3 | 2018 | 1451 | 0.16 | Why? |
| Bone and Bones | 1 | 2019 | 235 | 0.16 | Why? |
| Fatty Acids | 1 | 2018 | 238 | 0.16 | Why? |
| Energy Intake | 1 | 2019 | 323 | 0.16 | Why? |
| Minocycline | 1 | 2017 | 101 | 0.16 | Why? |
| Leptin | 1 | 2017 | 141 | 0.15 | Why? |
| Cell Transformation, Neoplastic | 1 | 2017 | 191 | 0.15 | Why? |
| Knee Joint | 1 | 2018 | 194 | 0.15 | Why? |
| Anti-Anxiety Agents | 1 | 2017 | 139 | 0.15 | Why? |
| Giant Cells | 1 | 2018 | 334 | 0.15 | Why? |
| Triglycerides | 1 | 2018 | 478 | 0.15 | Why? |
| Biological Specimen Banks | 2 | 2021 | 1142 | 0.15 | Why? |
| Sarcoma | 1 | 2019 | 290 | 0.15 | Why? |
| Decision Support Systems, Clinical | 1 | 2021 | 551 | 0.15 | Why? |
| Patient Dropouts | 1 | 2015 | 96 | 0.15 | Why? |
| Adrenomedullin | 1 | 2018 | 217 | 0.15 | Why? |
| Lymphatic Metastasis | 4 | 2018 | 537 | 0.14 | Why? |
| Adiposity | 1 | 2018 | 329 | 0.14 | Why? |
| Chronic Disease | 3 | 2018 | 5139 | 0.14 | Why? |
| Cholangiocarcinoma | 1 | 2017 | 186 | 0.14 | Why? |
| Prostatic Neoplasms | 2 | 2017 | 1637 | 0.14 | Why? |
| Nuclear Proteins | 1 | 2017 | 321 | 0.14 | Why? |
| B7-H1 Antigen | 1 | 2018 | 541 | 0.14 | Why? |
| Bile Duct Neoplasms | 1 | 2017 | 172 | 0.14 | Why? |
| Retrospective Studies | 11 | 2021 | 105322 | 0.14 | Why? |
| North America | 1 | 2019 | 1400 | 0.13 | Why? |
| Protein Precursors | 1 | 2018 | 425 | 0.13 | Why? |
| Predictive Value of Tests | 6 | 2020 | 9537 | 0.13 | Why? |
| Receptors, Cell Surface | 1 | 2018 | 586 | 0.13 | Why? |
| Treatment Failure | 2 | 2018 | 2106 | 0.13 | Why? |
| Adult | 23 | 2021 | 244371 | 0.13 | Why? |
| Kaplan-Meier Estimate | 3 | 2018 | 4260 | 0.13 | Why? |
| Cigarette Smoking | 1 | 2018 | 337 | 0.13 | Why? |
| Chi-Square Distribution | 1 | 2017 | 961 | 0.13 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2018 | 724 | 0.13 | Why? |
| Prospective Studies | 7 | 2021 | 43301 | 0.13 | Why? |
| Osteoporosis | 1 | 2019 | 410 | 0.13 | Why? |
| Arthritis | 1 | 2017 | 288 | 0.13 | Why? |
| Risk Assessment | 7 | 2019 | 25439 | 0.13 | Why? |
| Rectal Neoplasms | 1 | 2017 | 278 | 0.13 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.13 | Why? |
| Age Factors | 4 | 2019 | 21039 | 0.13 | Why? |
| Ultrasonography | 2 | 2020 | 4409 | 0.13 | Why? |
| Mood Disorders | 1 | 2017 | 431 | 0.12 | Why? |
| Tobacco Smoking | 1 | 2017 | 349 | 0.12 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.12 | Why? |
| Databases, Factual | 2 | 2019 | 6248 | 0.12 | Why? |
| Antigens, CD | 1 | 2018 | 984 | 0.12 | Why? |
| Peru | 1 | 2017 | 1010 | 0.12 | Why? |
| Prevalence | 7 | 2021 | 25773 | 0.12 | Why? |
| Magnetic Resonance Spectroscopy | 1 | 2018 | 881 | 0.12 | Why? |
| Warfarin | 1 | 2017 | 402 | 0.12 | Why? |
| Polypharmacy | 1 | 2015 | 347 | 0.12 | Why? |
| Corynebacterium Infections | 1 | 2012 | 26 | 0.12 | Why? |
| Sex Factors | 3 | 2019 | 11014 | 0.12 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.12 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.12 | Why? |
| Smokers | 1 | 2018 | 550 | 0.12 | Why? |
| Corynebacterium | 1 | 2012 | 47 | 0.12 | Why? |
| Activities of Daily Living | 2 | 2018 | 1530 | 0.12 | Why? |
| Tuberculosis | 2 | 2018 | 2895 | 0.12 | Why? |
| Demography | 1 | 2019 | 1660 | 0.11 | Why? |
| Multivariate Analysis | 3 | 2018 | 5440 | 0.11 | Why? |
| Esophageal Neoplasms | 1 | 2017 | 357 | 0.11 | Why? |
| Cognition Disorders | 1 | 2017 | 574 | 0.11 | Why? |
| Stomach Neoplasms | 1 | 2017 | 477 | 0.11 | Why? |
| Lung | 1 | 2020 | 31049 | 0.11 | Why? |
| Feeding and Eating Disorders | 1 | 2017 | 525 | 0.11 | Why? |
| Outpatients | 3 | 2019 | 3417 | 0.11 | Why? |
| Extracellular Vesicles | 1 | 2017 | 607 | 0.10 | Why? |
| National Health Programs | 1 | 2017 | 807 | 0.10 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.10 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.10 | Why? |
| Survival Analysis | 3 | 2019 | 7592 | 0.10 | Why? |
| Europe | 4 | 2019 | 12702 | 0.10 | Why? |
| Developing Countries | 3 | 2020 | 4283 | 0.10 | Why? |
| Laparoscopy | 1 | 2021 | 1532 | 0.10 | Why? |
| Stress, Psychological | 3 | 2017 | 10231 | 0.10 | Why? |
| Personal Satisfaction | 1 | 2019 | 1243 | 0.10 | Why? |
| Cognitive Dysfunction | 2 | 2018 | 1389 | 0.10 | Why? |
| Alcoholism | 1 | 2017 | 691 | 0.09 | Why? |
| Cerebrovascular Disorders | 1 | 2017 | 1040 | 0.09 | Why? |
| Sexual and Gender Minorities | 1 | 2019 | 1019 | 0.09 | Why? |
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 896 | 0.09 | Why? |
| Logistic Models | 3 | 2018 | 9089 | 0.09 | Why? |
| Insulin | 1 | 2017 | 1316 | 0.09 | Why? |
| Biomarkers | 5 | 2019 | 23361 | 0.09 | Why? |
| Health Facilities | 1 | 2016 | 1230 | 0.09 | Why? |
| Age Distribution | 1 | 2018 | 3567 | 0.09 | Why? |
| Carcinoma, Squamous Cell | 1 | 2017 | 902 | 0.09 | Why? |
| Comorbidity | 5 | 2019 | 34796 | 0.09 | Why? |
| Hospitalization | 2 | 2021 | 54280 | 0.09 | Why? |
| Vitamins | 1 | 2017 | 1208 | 0.09 | Why? |
| Preoperative Care | 1 | 2017 | 1515 | 0.08 | Why? |
| Anticoagulants | 2 | 2020 | 9563 | 0.08 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.08 | Why? |
| Melanoma | 1 | 2018 | 1229 | 0.08 | Why? |
| Catheterization, Central Venous | 1 | 2012 | 458 | 0.08 | Why? |
| Schizophrenia | 1 | 2017 | 1018 | 0.08 | Why? |
| Blood Pressure | 1 | 2018 | 2198 | 0.08 | Why? |
| Depressive Disorder, Major | 1 | 2015 | 852 | 0.08 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 1510 | 0.08 | Why? |
| Perception | 1 | 2017 | 2827 | 0.08 | Why? |
| Australia | 1 | 2019 | 6306 | 0.08 | Why? |
| Alcohol Drinking | 1 | 2018 | 1663 | 0.08 | Why? |
| Communicable Diseases | 1 | 2021 | 2148 | 0.07 | Why? |
| Oxidative Stress | 1 | 2017 | 2050 | 0.07 | Why? |
| Chloroquine | 1 | 2020 | 3152 | 0.07 | Why? |
| Public Health | 3 | 2020 | 16359 | 0.07 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.07 | Why? |
| Surveys and Questionnaires | 5 | 2020 | 43792 | 0.07 | Why? |
| Neoplasm Metastasis | 2 | 2019 | 682 | 0.07 | Why? |
| Mobile Applications | 1 | 2021 | 3032 | 0.07 | Why? |
| Diabetes Mellitus, Type 2 | 2 | 2017 | 6166 | 0.07 | Why? |
| Early Detection of Cancer | 1 | 2017 | 1956 | 0.07 | Why? |
| Internationality | 1 | 2018 | 3297 | 0.07 | Why? |
| Skin Neoplasms | 1 | 2018 | 1679 | 0.07 | Why? |
| Evidence-Based Medicine | 1 | 2018 | 3228 | 0.07 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2017 | 3607 | 0.07 | Why? |
| Health Promotion | 1 | 2018 | 2020 | 0.07 | Why? |
| Socioeconomic Factors | 2 | 2019 | 8495 | 0.07 | Why? |
| Case-Control Studies | 3 | 2018 | 17671 | 0.07 | Why? |
| MicroRNAs | 1 | 2017 | 1787 | 0.07 | Why? |
| Vitamin D Deficiency | 1 | 2017 | 1782 | 0.06 | Why? |
| Intubation, Intratracheal | 1 | 2018 | 3962 | 0.06 | Why? |
| Anxiety | 2 | 2020 | 17311 | 0.06 | Why? |
| Hypoglycemic Agents | 1 | 2015 | 2165 | 0.06 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.06 | Why? |
| X-Linked Combined Immunodeficiency Diseases | 1 | 2021 | 4 | 0.06 | Why? |
| Triage | 1 | 2021 | 7151 | 0.06 | Why? |
| Kidney Failure, Chronic | 1 | 2018 | 3222 | 0.06 | Why? |
| Severity of Illness Index | 3 | 2018 | 48226 | 0.05 | Why? |
| Cation Transport Proteins | 1 | 2021 | 53 | 0.05 | Why? |
| Lung Neoplasms | 1 | 2018 | 3228 | 0.05 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.05 | Why? |
| Renal Dialysis | 1 | 2018 | 4358 | 0.05 | Why? |
| Health Policy | 1 | 2020 | 6242 | 0.05 | Why? |
| Immunohistochemistry | 2 | 2018 | 2275 | 0.05 | Why? |
| Arachidonate 15-Lipoxygenase | 1 | 2019 | 9 | 0.05 | Why? |
| Africa | 2 | 2020 | 2986 | 0.05 | Why? |
| Receptor, Cannabinoid, CB2 | 1 | 2019 | 19 | 0.05 | Why? |
| Apolipoprotein A-V | 1 | 2018 | 6 | 0.05 | Why? |
| Mexican Americans | 1 | 2018 | 13 | 0.05 | Why? |
| Cyclic AMP Response Element-Binding Protein | 1 | 2018 | 29 | 0.05 | Why? |
| gamma-Linolenic Acid | 1 | 2018 | 3 | 0.05 | Why? |
| Apolipoproteins | 1 | 2018 | 33 | 0.05 | Why? |
| Social Class | 2 | 2017 | 1360 | 0.05 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.05 | Why? |
| South America | 1 | 2020 | 565 | 0.05 | Why? |
| Hydrolysis | 1 | 2018 | 160 | 0.05 | Why? |
| Diabetes Mellitus | 1 | 2021 | 8207 | 0.05 | Why? |
| Paraspinal Muscles | 1 | 2018 | 45 | 0.05 | Why? |
| PPAR gamma | 1 | 2019 | 102 | 0.05 | Why? |
| Nutritive Value | 1 | 2019 | 100 | 0.05 | Why? |
| Venous Thromboembolism | 1 | 2017 | 4273 | 0.05 | Why? |
| Ambulances | 1 | 2021 | 287 | 0.04 | Why? |
| Histiocytes | 1 | 2018 | 97 | 0.04 | Why? |
| Bulimia Nervosa | 1 | 2017 | 25 | 0.04 | Why? |
| Laryngeal Masks | 1 | 2018 | 68 | 0.04 | Why? |
| Pneumonia | 1 | 2018 | 5652 | 0.04 | Why? |
| Glutathione Disulfide | 1 | 2017 | 23 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Mozambique | 1 | 2018 | 205 | 0.04 | Why? |
| Indiana | 1 | 2018 | 236 | 0.04 | Why? |
| Deoxyguanosine | 1 | 2017 | 19 | 0.04 | Why? |
| Isoprostanes | 1 | 2017 | 22 | 0.04 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.04 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.04 | Why? |
| Hypertriglyceridemia | 1 | 2018 | 90 | 0.04 | Why? |
| Esophagogastric Junction | 1 | 2017 | 30 | 0.04 | Why? |
| alpha-Tocopherol | 1 | 2017 | 37 | 0.04 | Why? |
| Bone Marrow Cells | 1 | 2018 | 186 | 0.04 | Why? |
| Nutrition Surveys | 1 | 2018 | 287 | 0.04 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.04 | Why? |
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2017 | 36 | 0.04 | Why? |
| Aldehydes | 1 | 2017 | 56 | 0.04 | Why? |
| Cachexia | 1 | 2018 | 75 | 0.04 | Why? |
| Anti-Bacterial Agents | 2 | 2017 | 10083 | 0.04 | Why? |
| Argentina | 1 | 2021 | 1141 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Chile | 1 | 2021 | 1095 | 0.04 | Why? |
| Treatment Outcome | 6 | 2021 | 51732 | 0.04 | Why? |
| Epstein-Barr Virus Infections | 1 | 2021 | 366 | 0.04 | Why? |
| Exome | 1 | 2017 | 207 | 0.04 | Why? |
| Health Surveys | 2 | 2017 | 2841 | 0.04 | Why? |
| Anorexia Nervosa | 1 | 2017 | 103 | 0.04 | Why? |
| Americas | 1 | 2017 | 418 | 0.04 | Why? |
| Sulfhydryl Compounds | 1 | 2017 | 104 | 0.04 | Why? |
| Barrett Esophagus | 1 | 2017 | 68 | 0.04 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.04 | Why? |
| Poverty | 2 | 2018 | 2302 | 0.04 | Why? |
| In Situ Hybridization | 1 | 2017 | 390 | 0.04 | Why? |
| Adolescent | 4 | 2020 | 86841 | 0.04 | Why? |
| Bone Marrow | 1 | 2018 | 492 | 0.04 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.04 | Why? |
| Multidetector Computed Tomography | 1 | 2018 | 307 | 0.04 | Why? |
| Glutathione | 1 | 2017 | 280 | 0.04 | Why? |
| Carcinogenesis | 1 | 2017 | 236 | 0.04 | Why? |
| Communicable Disease Control | 2 | 2021 | 29620 | 0.04 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.03 | Why? |
| Prostate | 1 | 2017 | 283 | 0.03 | Why? |
| Sepsis | 1 | 2012 | 3517 | 0.03 | Why? |
| Fatty Acids, Omega-3 | 1 | 2018 | 306 | 0.03 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.03 | Why? |
| Lipid Metabolism | 1 | 2018 | 572 | 0.03 | Why? |
| Psychiatric Status Rating Scales | 1 | 2020 | 1340 | 0.03 | Why? |
| Infant, Premature | 1 | 2018 | 883 | 0.03 | Why? |
| Respiration, Artificial | 1 | 2018 | 22116 | 0.03 | Why? |
| Vascular Calcification | 1 | 2018 | 396 | 0.03 | Why? |
| Weight Loss | 1 | 2019 | 826 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Energy Metabolism | 1 | 2017 | 451 | 0.03 | Why? |
| Sensitivity and Specificity | 3 | 2019 | 22971 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| Child, Preschool | 1 | 2017 | 36283 | 0.03 | Why? |
| Gene Frequency | 1 | 2017 | 1210 | 0.03 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 1014 | 0.03 | Why? |
| Weight Gain | 1 | 2017 | 552 | 0.03 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.03 | Why? |
| Secondary Prevention | 1 | 2017 | 762 | 0.03 | Why? |
| Down-Regulation | 1 | 2018 | 1416 | 0.03 | Why? |
| Reproducibility of Results | 2 | 2018 | 11304 | 0.03 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
| Mental Health | 1 | 2017 | 15770 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| History, 20th Century | 1 | 2016 | 1282 | 0.03 | Why? |
| Asia | 1 | 2017 | 2399 | 0.03 | Why? |
| Young Adult | 5 | 2018 | 93724 | 0.02 | Why? |
| Genome-Wide Association Study | 1 | 2017 | 1648 | 0.02 | Why? |
| Neuroimaging | 1 | 2017 | 1106 | 0.02 | Why? |
| Dexamethasone | 1 | 2021 | 2055 | 0.02 | Why? |
| Pain | 1 | 2017 | 1084 | 0.02 | Why? |
| Global Health | 3 | 2017 | 13911 | 0.02 | Why? |
| Administration, Oral | 1 | 2017 | 2340 | 0.02 | Why? |
| History, 21st Century | 1 | 2016 | 1849 | 0.02 | Why? |
| Self Care | 1 | 2017 | 918 | 0.02 | Why? |
| Musculoskeletal Diseases | 1 | 2016 | 646 | 0.02 | Why? |
| Cerebral Hemorrhage | 1 | 2017 | 820 | 0.02 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.02 | Why? |
| Up-Regulation | 1 | 2017 | 2249 | 0.02 | Why? |
| RNA, Ribosomal, 16S | 1 | 2012 | 793 | 0.02 | Why? |
| Neoplasms | 1 | 2017 | 17251 | 0.02 | Why? |
| Fatigue | 1 | 2019 | 2479 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Child | 1 | 2017 | 70012 | 0.02 | Why? |
| Oxygen | 1 | 2021 | 3715 | 0.02 | Why? |
| Anxiety Disorders | 1 | 2020 | 2290 | 0.02 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.02 | Why? |
| England | 1 | 2019 | 5116 | 0.02 | Why? |
| World Health Organization | 1 | 2020 | 4213 | 0.02 | Why? |
| Mutation | 2 | 2017 | 12376 | 0.02 | Why? |
| Employment | 1 | 2018 | 1754 | 0.02 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.02 | Why? |
| Germany | 1 | 2021 | 9196 | 0.02 | Why? |
| Genotype | 1 | 2017 | 4697 | 0.02 | Why? |
| Health Care Surveys | 1 | 2015 | 2942 | 0.02 | Why? |
| Lymphocytes | 1 | 2018 | 3056 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| RNA, Messenger | 1 | 2019 | 5131 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Algorithms | 1 | 2021 | 7346 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.02 | Why? |
| Consensus | 1 | 2018 | 6345 | 0.02 | Why? |
| Diabetes Complications | 1 | 2015 | 2358 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2012 | 1318 | 0.02 | Why? |
| Brazil | 1 | 2020 | 12582 | 0.02 | Why? |
| China | 2 | 2020 | 50654 | 0.01 | Why? |
| Health Behavior | 1 | 2020 | 4449 | 0.01 | Why? |
| Patient Discharge | 1 | 2018 | 5696 | 0.01 | Why? |
| Patient Admission | 1 | 2018 | 5250 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Brain | 1 | 2017 | 5133 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2017 | 13720 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Time Factors | 1 | 2019 | 31397 | 0.01 | Why? |
| Mental Disorders | 1 | 2017 | 6742 | 0.01 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2018 | 25144 | 0.01 | Why? |
| United States | 1 | 2018 | 46150 | 0.01 | Why? |
| Animals | 1 | 2018 | 78931 | 0.01 | Why? |